SUBSCRIBE: Print / eNewsletter
Check out our resource centers on specific hematologic malignancies for the latest news and information on the treatment of these diseases.
Study Identifies Clinical Factors That Predict Outcome in Aggressive Non-Hodgkin's Lymphoma
Today, we can cure a significant portion of people with aggressive non-Hodgkin's lymphomas. The cure rate at 5 years for all patients with advanced diffuse large-cell lymphoma is approximately 35%.
Current Management of Primary Central Nervous System Lymphoma
Primary CNS lymphoma is rising in incidence in both the AIDS and non-AIDS populations. It is a non-Hodgkin's lymphoma that usually presents as a brain tumor, but the leptomeninges, eyes, and spinal cord also are
Arsenic trioxide consolidation was well tolerated in pediatric patients with acute promyelocytic leukemia and allowed for significant reductions in cumulative anthracycline doses.